Clinical Trial

Multiomic Diagnostics in Youth With Psychosis

Recruiting

Record status

This record was last updated November 14, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

Summary

Rady Children's Institute for Genomic Medicine seeks to understand the genomes and immune systems in 15 children and adolescents who are admitted to Rady Children's Hospital Child and Adolescent Psychiatry Service with psychotic symptoms or schizophrenia. Cutting-edge genome and protein sequencing technology will be used to better understand how immunological and genetic assessments may improve our ability to identify the cause of psychosis and impact care. The investigator also hopes to identify new genetic and/or autoimmune causes of psychosis that may inform new treatment for future patients.

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2022-07-08; most recent amendment 2024-11-12.

Status change: Not Yet Recruiting → Recruiting 2022-10-24

Trial Details

NCT Number	NCT05457140
Lead Sponsor	Rady Pediatric Genomics & Systems Medicine Institute
Conditions	Psychosis
Enrollment	15 participants
Start Date	2022-10-10
Primary Completion	2025-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2024-11-14